<code id='E52E1F0D45'></code><style id='E52E1F0D45'></style>
    • <acronym id='E52E1F0D45'></acronym>
      <center id='E52E1F0D45'><center id='E52E1F0D45'><tfoot id='E52E1F0D45'></tfoot></center><abbr id='E52E1F0D45'><dir id='E52E1F0D45'><tfoot id='E52E1F0D45'></tfoot><noframes id='E52E1F0D45'>

    • <optgroup id='E52E1F0D45'><strike id='E52E1F0D45'><sup id='E52E1F0D45'></sup></strike><code id='E52E1F0D45'></code></optgroup>
        1. <b id='E52E1F0D45'><label id='E52E1F0D45'><select id='E52E1F0D45'><dt id='E52E1F0D45'><span id='E52E1F0D45'></span></dt></select></label></b><u id='E52E1F0D45'></u>
          <i id='E52E1F0D45'><strike id='E52E1F0D45'><tt id='E52E1F0D45'><pre id='E52E1F0D45'></pre></tt></strike></i>

          focus

          focus

          author:Wikipedia    Page View:79541

          Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

          This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.  

          advertisement

          To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          knowledge

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban
          R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

          ApackofR.J.Reynolds'newCamelCrushcigarettesforsaleinCaliforniaNicholasFlorko/STATWASHINGTON–Tobaccog

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

          Bayer'sU.S.president,SebastianGuth,emphasizedataninterviewattheSTATofficesinBostonthatthepharmacompa